drugset / Trial / NCT02612181

Dex on Microcirculation in SS-A Double-blinded Study

NCT02612181 ↗

Phase 4 Unknown 44 enrolled Southeast University, China
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The investigators preliminary study showed that dexmedetomidine might improve microcirculation in septic shock patients. To test this effect, the investigators will conduct double-blinded study.

Timeline

Start
2016-01
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.7 ug/kg —